Stryker recalls 167 angiographic catheters

Stryker Sustainability Solutions voluntarily recalled 167 of its Angiodynamics Soft Vu Omni Flush angiographic catheters.

The company received reports of the tip of the catheter separating from the main body, which could lead to loss of device function, surgical intervention or other complications. The tip separation can also cause organ injury, stroke, kidney failure, intestinal failure and death in some circumstances, according to an FDA release on July 22.

Healthcare professionals use the catheters to inject dye into the blood vessels to prepare for a cardiac angiogram. They insert the catheters through a small skin puncture and into a blood vessel.

The recalled products were manufactured from Nov. 7, 2003, to Oct. 18, 2008, and distributed from Jan. 5, 2004, to Dec. 3, 2008.

Stryker recalled devices in Texas, Utah, Pennsylvania, California, Vermont, Maine, Washington, Virginia, New York, Maryland and Connecticut.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.